Dr. Wachsman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Gilman Dr
Hematologyoncology 9111e
La Jolla, CA 92093Phone+1 858-552-8585Fax+1 858-552-7416
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1982 - 1985
University of MinnesotaResidency, Internal Medicine, 1978 - 1981
Case Western Reserve University School of MedicineClass of 1978
Certifications & Licensure
CA State Medical License 1983 - 2026
MN State Medical License 1981 - 1981- American Board of Internal Medicine Internal Medicine
Clinical Trials
- Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin Lymphoma Start of enrollment: 2007 Nov 01
- Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials Start of enrollment: 2008 May 14
- Lenalidomide in Treating Patients With AIDS-Associated Kaposi's Sarcoma Start of enrollment: 2010 Aug 27
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsPhase I Trial of the Multi-kinase Inhibitor Cabozantinib, a CYP3A4 Substrate, plus CYP3A4-Interacting Antiretroviral Therapy in People Living with HIV and Cancer (AMC-...Missak Haigentz Jr, Jeannette Y Lee, Elizabeth Y Chiao, David M Aboulafia, Lee Ratner
Clinical Cancer Research. 2023-12-15 - 7 citationsAMC-070: Lenalidomide Is Safe and Effective in HIV-Associated Kaposi Sarcoma.Erin G Reid, Kelly Shimabukuro, Page Moore, Richard F Ambinder, Jack D Bui
Clinical Cancer Research. 2022-06-13 - 1 citationsImmune Recovery Following Autologous Hematopoietic Stem Cell Transplantation in HIV-Related Lymphoma Patients on the BMT CTN 0803/AMC 071 TrialPolina Shindiapina, Maciej Pietrzak, Michal Seweryn, Eric McLaughlin, Xiaoli Zhang
Frontiers in Immunology. 2021-09-03
Abstracts/Posters
- Comparative Analysis of Immune Reconstitution in HIV-Positive Recipients of Allogeneic and Autologous Stem Cell Transplant on the BMT CTN 0903/AMC-080 and BMT CTN 0803...William Wachsman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Response-Adapted Therapy with Infusional EPOCH Chemotherapy Plus Rituximab in HIV-Associated, B-Cell Non-Hodgkin's LymphomaWilliam Wachsman, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Grant Support
- UCSD Core SiteNational Cancer Institute2010–2011
- University Of California - SAN DiegoNational Cancer Institute2006
- Aids-Related Malignancies Consortium--Uc SAN DiegoNational Cancer Institute2002–2005
- Viral MalignancyNational Cancer Institute2001–2002
- Core--MicroarrayNational Cancer Institute2001–2002
- Viral CarcinogenesisNational Cancer Institute2000
- Tax Response Complex-1 And HTLV PathogenesisNational Cancer Institute1994–1996
- Molecular Studies On HTLV X Gene Product/Ltr InteractionNational Cancer Institute1987–1988
- Human Retroviruses And Hairy-Cell LeukemiaNational Cancer Institute1987–1988
- Molecular Studies--Hltv X Gene Product-Ltr InteractionNational Cancer Institute1986–1987
- Human Retroviruses And Hairy-Cell LeukemiaNational Cancer Institute1986–1987
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
